Worldwide Network for Blood and Marrow Transplantation Recommendations for Establishing a Hematopoietic Stem Cell Transplantation Program in Countries with Limited Resources, Part II: Clinical, Technical, and Socioeconomic Considerations.


Journal

Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation
ISSN: 1523-6536
Titre abrégé: Biol Blood Marrow Transplant
Pays: United States
ID NLM: 9600628

Informations de publication

Date de publication:
12 2019
Historique:
received: 28 02 2019
revised: 07 04 2019
accepted: 09 04 2019
pubmed: 20 4 2019
medline: 9 9 2020
entrez: 20 4 2019
Statut: ppublish

Résumé

The development of hematopoietic stem cell transplantation (HSCT) programs can face significant challenges in most developing countries because such endeavors must compete with other government health care priorities, including the delivery of basic services. Although this is may be a limiting factor, these countries should prioritize development of the needed expertise to offer state-of-the-art treatments, including transplantation, by providing financial, technological, legal, ethical, and other needed support. This would prove beneficial in providing successful programs customized to the needs of their population and potentially provide long-term cost savings by circumventing the need for their citizens to seek care abroad. The costs of establishing an HSCT program and the costs of the HSCT procedure itself can be substantial barriers in developing countries. In addition, socioeconomic factors intrinsic to specific countries can influence access to HSCT, patient eligibility for HSCT, and timely utilization of HSCT center capabilities. This report describes recommendations from the Worldwide Network for Blood and Marrow Transplantation for establishing HSCT programs, with a specific focus on developing countries, and identifies challenges and opportunities for providing this specialized procedure in resource-constrained settings.

Identifiants

pubmed: 31002990
pii: S1083-8791(19)30235-6
doi: 10.1016/j.bbmt.2019.04.012
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

2330-2337

Informations de copyright

Copyright © 2019 American Society for Transplantation and Cellular Therapy. Published by Elsevier Inc. All rights reserved.

Auteurs

Mahmoud Aljurf (M)

Hematology Department, King Faisal Specialist Hospital & Research Centre, Riyadh, Saudi Arabia. Electronic address: maljurf@kfshrc.edu.sa.

Daniel Weisdorf (D)

University of Minnesota, Minneapolis, Minnesota.

Shahrukh Hashmi (S)

Hematology Department, King Faisal Specialist Hospital & Research Centre, Riyadh, Saudi Arabia; Department of Medicine, Mayo Clinic, Rochester, Minnesota.

Amr Nassar (A)

National Cancer Institute, Cairo University, Cairo, Egypt.

Eliane Gluckman (E)

Eurocord Hôpital Saint-Louis and University Paris Diderot, Paris, France.

Mohamad Mohty (M)

Hopital Saint-Antoine, Sorbonne University, Paris, France.

Doug Rizzo (D)

Center for International Blood and Marrow Transplant Research, Milwaukee, Wisconsin.

Marcelo Pasquini (M)

Center for International Blood and Marrow Transplant Research, Milwaukee, Wisconsin.

Mehdi Hamadani (M)

Center for International Blood and Marrow Transplant Research, Milwaukee, Wisconsin.

Wael Saber (W)

Center for International Blood and Marrow Transplant Research, Milwaukee, Wisconsin.

Parameswaran Hari (P)

Center for International Blood and Marrow Transplant Research, Milwaukee, Wisconsin.

Mohamed Kharfan-Dabaja (M)

Department of Medicine, Division of Hematology-Oncology and Blood and Marrow Transplantation program, Mayo Clinic, Jacksonville, Florida.

Navneet Majhail (N)

Blood and Marrow Transplant Program, Cleveland Clinic, Cleveland, Ohio.

Usama Gerges (U)

Hematologic Malignancies & Bone Marrow Transplant, Department of Medicial Oncology, New York-Presbyterian Hospital/Weill Cornell Medical Center, New York, New York.

Amir Ali Hamidieh (AA)

Hematology, Oncology and SCT Research Center, Tehran University of Medical Sciences, Tehran, Iran.

Fazal Hussain (F)

Hematology Department, King Faisal Specialist Hospital & Research Centre, Riyadh, Saudi Arabia.

Alaa Elhaddad (A)

National Cancer Institute, Cairo University, Cairo, Egypt.

Hossam K Mahmoud (HK)

National Cancer Institute, Cairo University, Cairo, Egypt.

Abdelghani Tbakhi (A)

King Hussein Cancer Center, Amman, Jordan.

Tarek Ben Othman (TB)

Center National de Greffe de Moelle Osseuse de Tunis, Tunis, Tunisia.

Rose-Marie Hamladji (RM)

Pierre and Marie Curie Center, Algiers, Algeria.

Mohamed Amine Bekadja (MA)

University Hospital Establishment 1st Nov, Oran, Algeria.

Parvez Ahmed (P)

Armed Forces Institute of Transplantation, Rawalpindi, Pakistan.

Ali Bazarbachi (A)

Department of Hematology/Oncology, American University of Beirut Medical Center, Beirut, Lebanon.

Salman Adil (S)

Aga Khan University Hospital, Karachi, Pakistan.

Salman Alkindi (S)

Sultan Qaboos University Hospital, Muscat, Oman.

Saleh Ladeb (S)

Center National de Greffe de Moelle Osseuse de Tunis, Tunis, Tunisia.

David Dennison (D)

Sultan Qaboos University Hospital, Muscat, Oman.

Moosa Patel (M)

University of the Witwatersrand, Johannesburg, South Africa.

Peihua Lu (P)

Hebei Yanda Ludaopei Hospital, Langfang, China.

Asma El Quessar (AE)

Hôpital 20 Août, Casablanca, Morocco.

Shinichiro Okamoto (S)

Japanese Data Center for Hematopoietic Cell Transplantation, Nagoya, Japan.

Yoshiko Atsuta (Y)

Keio University School of Medicine, Tokyo, Japan.

Ayman Alhejazi (A)

King Abdulaziz Medical City, NGHA, Riyadh, Saudi Arabia.

Mouhab F Ayas (MF)

Hematology Department, King Faisal Specialist Hospital & Research Centre, Riyadh, Saudi Arabia.

Syed O Ahmed (SO)

Hematology Department, King Faisal Specialist Hospital & Research Centre, Riyadh, Saudi Arabia.

Nickolas Novitzky (N)

African Blood & Marrow Transplantation Society, South Africa.

Alok Srivastava (A)

Christian Medical College and Hospital, Bagayam, Vellore, India.

Adriana Seber (A)

Instituto de Oncologia Pediatrica, Sao Paulo, Brazil.

Hassan El Solh (HE)

Hematology Department, King Faisal Specialist Hospital & Research Centre, Riyadh, Saudi Arabia.

Ardeshir Ghavamzadeh (A)

Hematology, Oncology and SCT Research Center, Tehran University of Medical Sciences, Tehran, Iran.

Dennis Confer (D)

Center for International Blood and Marrow Transplant Research, Milwaukee, Wisconsin.

Yoshihisa Kodera (Y)

Center for Hematopoietic Stem Cell Transplantation, Aichi Medical University Hospital, Nagakute, Japan.

Greinix Hildegard (G)

Medical University of Graz, Graz, Austria.

Jeff Szer (J)

Department of Clinical Haematology, Royal Melbourne Hospital, Melbourne, Australia.

Mary M Horowitz (MM)

Center for International Blood and Marrow Transplant Research, Milwaukee, Wisconsin.

Dietger Niederwieser (D)

Center for Hematopoietic Stem Cell Transplantation, Aichi Medical University Hospital, Nagakute, Japan; Department of Hematology and Medical Oncology, University Hospital, Leipzig, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH